Skip to main content

Advertisement

SpringerLink
Log in

Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer

  • Brief Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Neurofibromatosis type 1 (NF1) is a common dominant autosomal disorder caused by mutations in the NF1 gene. The main manifestations of NF1 are café-au-lait spots, neurofibromas, intertriginous freckling, Lisch nodules, and malignancy, including peripheral nerve sheath tumors, central nervous system gliomas, and a variety of other tumors not so clearly defined. The association between NF1 and breast cancer or other gynecologic malignancies seems uncommon and has been scarcely referred in the literature. We describe a family with two females affected by both NF1 and early-onset breast cancer, and a male with NF1. We evaluated whether the concomitance of both disorders could be attributed to a NF1 mutation and its supposed increased risk of breast cancer or to the concurrence of two NF1 and BRCA1/2 germline mutations. Mutation analyses identified a frameshift mutation in BRCA1 and a nonsense mutation in NF1. Our findings stress the importance of considering all phenotypic features in families with both NF1 and breast tumors. To offer a specific risk assessment and management of both conditions, NF1 and BRCA1/2 cancer predisposing genes should be analyzed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151(1):33–40

    Article  PubMed  CAS  Google Scholar 

  2. Brems H, Beert E, de Ravel T, Legius E (2009) Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 10(5):508–515

    Article  PubMed  CAS  Google Scholar 

  3. Sorensen SA, Mulvihill JJ, Nielsen A (1986) Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 314(16):1010–1015

    Article  PubMed  CAS  Google Scholar 

  4. Zoller ME, Rembeck B, Oden A, Samuelsson M, Angervall L (1997) Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 79(11):2125–2131

    Article  PubMed  CAS  Google Scholar 

  5. Korf BR (2000) Malignancy in neurofibromatosis type 1. Oncologist 5(6):477–485

    Article  PubMed  CAS  Google Scholar 

  6. Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I, Baralle D (2006) A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 95(2):233–238

    Article  PubMed  CAS  Google Scholar 

  7. Yohay K (2009) Neurofibromatosis type 1 and associated malignancies. Curr Neurol Neurosci Rep 9(3):247–253

    Article  PubMed  CAS  Google Scholar 

  8. Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56(1):265–271

    PubMed  CAS  Google Scholar 

  9. Whittemore AS, Gong G, Itnyre J (1997) Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 60(3):496–504

    PubMed  CAS  Google Scholar 

  10. Yaegashi S, Sachse R, Ohuchi N, Mori S, Sekiya T (1995) Low incidence of a nucleotide sequence alteration of the neurofibromatosis 2 gene in human breast cancers. Jpn J Cancer Res 86(10):929–933

    Article  PubMed  CAS  Google Scholar 

  11. Ogata H, Sato H, Takatsuka J, De Luca LM (2001) Human breast cancer MDA-MB-231 cells fail to express the neurofibromin protein, lack its type I mRNA isoform and show accumulation of P-MAPK and activated Ras. Cancer Lett 172(2):159–164

    Article  PubMed  CAS  Google Scholar 

  12. Nakamura M, Tangoku A, Kusanagi H, Oka M, Suzuki T (1998) Breast cancer associated with Recklinghausen’s disease: report of a case. Nihon Geka Hokan 67(1):3–9

    PubMed  CAS  Google Scholar 

  13. el-Zawahry MD, Farid M, Abd el-Latif A, Horeia H, el-Gindy M, Twakal G (1989) Breast lesions in generalized neurofibromatosis: breast cancer and cystosarcoma phylloides. Neurofibromatosis 2(2):121–124

    PubMed  CAS  Google Scholar 

  14. Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 95 % of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15(6):541–555

    Article  PubMed  CAS  Google Scholar 

  15. den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15(1):7–12

    Article  Google Scholar 

  16. Rasmussen SA, Yang Q, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68(5):1110–1118

    Article  PubMed  CAS  Google Scholar 

  17. Murayama Y, Yamamoto Y, Shimojima N, Takahara T, Kikuchi K, Iida S, Kondo Y (1999) Ti breast cancer associated with Von Recklinghausen’s neurofibromatosis. Breast Cancer 6(3):227–230

    Article  CAS  Google Scholar 

  18. Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, Evans DG (2007) Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44(8):481–484

    Article  PubMed  CAS  Google Scholar 

  19. Ceccaroni M, Genuardi M, Legge F, Lucci-Cordisco E, Carrara S, D’Amico F, Greggi S, Scambia G (2002) BRCA1-related malignancies in a family presenting with von Recklinghausen’s disease. Gynecol Oncol 86(3):375–378

    Article  PubMed  Google Scholar 

  20. Guran S, Safali M (2005) A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer. Cancer Genet Cytogenet 156(1):86–88

    Article  PubMed  Google Scholar 

  21. Salemis NS, Nakos G, Sambaziotis D, Gourgiotis S (2010) Breast cancer associated with type 1 neurofibromatosis. Breast Cancer 17(4):306–309

    Article  PubMed  Google Scholar 

  22. Madanikia SA, Bergner A, Ye X, Blakeley JO (2012) Increased risk of breast cancer in women with NF1. Am J Med Genet A 158A(12):3056–3060

    Article  PubMed  Google Scholar 

  23. Wang X, Levin AM, Smolinski SE, Vigneau FD, Levin NK, Tainsky MA (2012) Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area. Am J Med Genet A 158A(12):3061–3064

    Article  PubMed  CAS  Google Scholar 

  24. Wilson CH, Griffith CD, Shrimankar J, Douglas F (2004) Gynaecomastia, neurofibromatosis and breast cancer. Breast 13(1):77–79

    Article  PubMed  Google Scholar 

  25. Bradbury AR, Olopade OI (2007) Genetic susceptibility to breast cancer. Rev Endocr Metab Disord 8(3):255–267

    Article  PubMed  Google Scholar 

  26. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF Jr, Li FP (1991) Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 51(22):6094–6097

    PubMed  CAS  Google Scholar 

  27. Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJ, Keller JJ, Westerman AM, Scott RJ, Lim W, Trimbath JD, Giardiello FM, Gruber SB, Offerhaus GJ, de Rooij FW, Wilson JH, Hansmann A, Moslein G, Royer-Pokora B, Vogel T, Phillips RK, Spigelman AD, Houlston RS (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12(10):3209–3215

    Article  PubMed  CAS  Google Scholar 

  28. Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Gilpin C, Nikkel S, Connolly-Wilson M, Weissman S, Rubinstein WS, Sebold C, Greenstein R, Stroop J, Yim D, Panzini B, McKinnon W, Greenblatt M, Wirtzfeld D, Fontaine D, Coit D, Yoon S, Chung D, Lauwers G, Pizzuti A, Vaccaro C, Redal MA, Oliveira C, Tischkowitz M, Olschwang S, Gallinger S, Lynch H, Green J, Ford J, Pharoah P, Fernandez B, Huntsman D (2007) Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 297(21):2360–2372

    Article  PubMed  CAS  Google Scholar 

  29. Bogdanova N, Feshchenko S, Schurmann P, Waltes R, Wieland B, Hillemanns P, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Varon R, Dork T (2008) Nijmegen breakage syndrome mutations and risk of breast cancer. Int J Cancer 122(4):802–806

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the proband and her family for their participation in this study. All research carried out for this study complies with the current laws of Spain.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Center for Molecular Genetic Diagnosis (CDGM)—IDIBELL, Gran Via de l’Hospitalet, 199, 08908, L’Hospitalet de Llobregat, Spain

    Berta Campos, Josep Gardenyes, Oscar Abad, Pere Fàbregas & Víctor Volpini

  2. High Risk and Cancer Prevention Unit, Medical Oncology Department, University Hospital Vall Hebron, Barcelona, Spain

    Judith Balmaña

  3. Genetics Unit, University Hospital Vall d’Hebron, Barcelona, Spain

    Irene Valenzuela

  4. Oncogenetics Laboratory, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain

    Orland Díez

Authors
  1. Berta Campos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judith Balmaña
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Josep Gardenyes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Irene Valenzuela
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Oscar Abad
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pere Fàbregas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Víctor Volpini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Orland Díez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Berta Campos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Campos, B., Balmaña, J., Gardenyes, J. et al. Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer. Breast Cancer Res Treat 139, 597–602 (2013). https://doi.org/10.1007/s10549-013-2538-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-013-2538-6

Keywords

Search

Navigation